Brimonidine is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Brimonidine Tartrate.
Product ID | 50090-1046_47e74411-fd63-40a8-a821-d54ce163ce06 |
NDC | 50090-1046 |
Product Type | Human Prescription Drug |
Proprietary Name | Brimonidine |
Generic Name | Brimonidine Tartrate |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2006-09-07 |
Marketing Category | ANDA / |
Application Number | ANDA076439 |
Labeler Name | A-S Medication Solutions |
Substance Name | BRIMONIDINE TARTRATE |
Active Ingredient Strength | 2 mg/mL |
Pharm Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2014-11-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA076439 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-12-26 |
Marketing End Date | 2017-12-26 |
NDC | Brand Name | Generic Name |
---|---|---|
17478-715 | Brimonidine | Brimonidine Tartrate |
45802-078 | BRIMONIDINE | brimonidine |
50090-1046 | Brimonidine | Brimonidine Tartrate |
0023-9177 | ALPHAGAN P | brimonidine tartrate |
0023-9321 | ALPHAGAN P | brimonidine tartrate |
14445-400 | Brimonidine Tartrate | Brimonidine Tartrate |
24208-411 | Brimonidine Tartrate | Brimonidine Tartrate |
25685-715 | Brimonidine Tartrate | brimonidine tartrate |
42843-501 | Brimonidine Tartrate | Brimonidine Tartrate |
50090-1800 | Brimonidine Tartrate | Brimonidine Tartrate |
50090-4224 | Brimonidine Tartrate | Brimonidine Tartrate |
60505-0564 | Brimonidine Tartrate | brimonidine tartrate |
61314-143 | Brimonidine Tartrate | Brimonidine Tartrate |
61314-144 | Brimonidine Tartrate | Brimonidine Tartrate |
24208-537 | LUMIFY Redness Reliever Eye Drops | BRIMONIDINE TARTRATE |
0299-5980 | Mirvaso | brimonidine tartrate |